Acceleration of wound healing using adipose mesenchymal stem cell secretome hydrogel on partial-thickness cutaneous thermal burn wounds: An

drug safety mesenchymal stem cell-conditioned media stem cell-free-therapy thermal injury wound healing

Journal

Veterinary world
ISSN: 0972-8988
Titre abrégé: Vet World
Pays: India
ID NLM: 101504872

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 05 03 2024
accepted: 21 06 2024
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 26 8 2024
Statut: ppublish

Résumé

The intricate healing process involves distinct sequential and overlapping phases in thermal injury. To maintain the zone of stasis in Jackson's burn wound model, proper wound intervention is essential. The extent of research on the histoarchitecture of thermal wound healing and the application of mesenchymal stem cell (MSC)-free-based therapy is limited. This study aimed to assess the efficacy of MSC-secretome-based hydrogel for treating partial-thickness cutaneous thermal burn wounds. Eighteen male Wistar rats were divided into three groups, namely the hydrogel base (10 mg), hydrogel secretome (10 mg) and Bioplacenton™ (10 mg) treatment groups. All groups were treated twice a day (morning and evening) for 7 days. Skin tissue samples from the animals were processed for histological evaluation using the formalin-fixed paraffin-embedded method on days 3 and 7. This study's findings showed that secretome hydrogel expedited thermal burn wound healing, decreasing residual burn area, boosting collagen deposition and angiogenesis, guiding scar formation, and influencing the inflammation response facilitated by polymorphonuclear leukocytes and macrophages. The secretome hydrogel significantly improves healing outcomes in partial-thickness cutaneous thermal burn wounds. The administration of secretome hydrogel accelerates the reduction of the residual burn area and promotes fibroblast proliferation and collagen density. The repairment of histo-architecture of the damaged tissue was also observed such as the reduction of burn depth, increased angiogenesis and epidermal scar index while the decreased dermal scar index. Furthermore, the secretome hydrogel can modulate the immunocompetent cells by decreasing the polymorphonuclear and increasing the mononuclear cells. Thus, it effectively and safely substitutes for thermal injury stem cell-free therapeutic approaches. The study focuses on the microscopical evaluation of secretome hydrogel; further research to investigate at the molecular level may be useful in predicting the beneficial effect of secretome hydrogel in accelerating wound healing.

Sections du résumé

Background and Aim UNASSIGNED
The intricate healing process involves distinct sequential and overlapping phases in thermal injury. To maintain the zone of stasis in Jackson's burn wound model, proper wound intervention is essential. The extent of research on the histoarchitecture of thermal wound healing and the application of mesenchymal stem cell (MSC)-free-based therapy is limited. This study aimed to assess the efficacy of MSC-secretome-based hydrogel for treating partial-thickness cutaneous thermal burn wounds.
Materials and Methods UNASSIGNED
Eighteen male Wistar rats were divided into three groups, namely the hydrogel base (10 mg), hydrogel secretome (10 mg) and Bioplacenton™ (10 mg) treatment groups. All groups were treated twice a day (morning and evening) for 7 days. Skin tissue samples from the animals were processed for histological evaluation using the formalin-fixed paraffin-embedded method on days 3 and 7.
Results UNASSIGNED
This study's findings showed that secretome hydrogel expedited thermal burn wound healing, decreasing residual burn area, boosting collagen deposition and angiogenesis, guiding scar formation, and influencing the inflammation response facilitated by polymorphonuclear leukocytes and macrophages.
Conclusion UNASSIGNED
The secretome hydrogel significantly improves healing outcomes in partial-thickness cutaneous thermal burn wounds. The administration of secretome hydrogel accelerates the reduction of the residual burn area and promotes fibroblast proliferation and collagen density. The repairment of histo-architecture of the damaged tissue was also observed such as the reduction of burn depth, increased angiogenesis and epidermal scar index while the decreased dermal scar index. Furthermore, the secretome hydrogel can modulate the immunocompetent cells by decreasing the polymorphonuclear and increasing the mononuclear cells. Thus, it effectively and safely substitutes for thermal injury stem cell-free therapeutic approaches. The study focuses on the microscopical evaluation of secretome hydrogel; further research to investigate at the molecular level may be useful in predicting the beneficial effect of secretome hydrogel in accelerating wound healing.

Identifiants

pubmed: 39185045
doi: 10.14202/vetworld.2024.1545-1554
pii: Vetworld-17-1545
pmc: PMC11344119
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1545-1554

Informations de copyright

Copyright: © Kuncorojakti, et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Suryo Kuncorojakti (S)

Division of Veterinary Anatomy, Department of Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia.
Research Centre for Vaccine Technology and Development, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.

Awidhan Zainal Adi Pratama (AZA)

Department of Pharmaceutics Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya, Indonesia.

Cahya Asri Antujala (CA)

Department of Pharmaceutics Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya, Indonesia.

Clarence Theodosius Bernard Harijanto (CTB)

Department of Pharmaceutics Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya, Indonesia.

Rozak Kurnia Arsy (RK)

Department of Pharmaceutics Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya, Indonesia.

Putut Andika Kurniawan (PA)

Department of Pharmaceutics Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya, Indonesia.

Yudy Tjahjono (Y)

Department of Pharmaceutics Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya, Indonesia.

Lucia Hendriati (L)

Department of Pharmaceutics Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya, Indonesia.

Teguh Widodo (T)

Department of Pharmaceutics Faculty of Pharmacy, Widya Mandala Catholic University, Surabaya, Indonesia.

Ahmad Aswin (A)

Research Centre for Vaccine Technology and Development, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.

Diyantoro Diyantoro (D)

Research Centre for Vaccine Technology and Development, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.
Department of Health, Faculty of Vocational Studies, Universitas Airlangga, Surabaya, Indonesia.

Andi Yasmin Wijaya (AY)

Research Centre for Vaccine Technology and Development, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.

Watchareewan Rodprasert (W)

Veterinary Stem Cell and Bioengineering Innovation Center, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.

Helen Susilowati (H)

Research Centre for Vaccine Technology and Development, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia.

Classifications MeSH